Progress of mantle cell lymphoma
10.3760/cma.j.issn.1009-9921.2019.11.017
- VernacularTitle: 套细胞淋巴瘤研究进展
- Author:
Caiqin WANG
1
;
Tianxiao GAO
;
Xiaoqing SUN
;
Zhiming LI
Author Information
1. Sun Yat-Sen University Cancer Center, Guangzhou 510060, China
- Publication Type:Review
- Keywords:
Lymphoma, mantle-cell;
Epidemiology;
Treatment;
Progress
- From:
Journal of Leukemia & Lymphoma
2019;28(11):701-704
- CountryChina
- Language:Chinese
-
Abstract:
Mantle cell lymphoma (MCL) is an aggressive and rare B-cell lymphoma, accounting for around 6%-8% of non-Hodgkin's lymphoma (NHL). Up to now, there are a lot of studies and reports on the biological behavior, diagnostic criteria and treatments of MCL worldwide. However, due to its high invasiveness, there are still many problems to be solved in terms of prognosis and treatment. This article introduces MCL and its progress in the unsolved clinical problems.
